nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—autistic disorder	0.414	1	CbGaD
Celecoxib—PDPK1—forebrain—autistic disorder	0.00861	0.0424	CbGeAlD
Celecoxib—MAPK14—hindbrain—autistic disorder	0.00832	0.041	CbGeAlD
Celecoxib—CA6—mouth—autistic disorder	0.00826	0.0407	CbGeAlD
Celecoxib—MAPK14—mouth—autistic disorder	0.0073	0.036	CbGeAlD
Celecoxib—PDPK1—digestive system—autistic disorder	0.00604	0.0298	CbGeAlD
Celecoxib—PDPK1—head—autistic disorder	0.00493	0.0243	CbGeAlD
Celecoxib—MAPK14—brainstem—autistic disorder	0.00477	0.0235	CbGeAlD
Celecoxib—PDPK1—nervous system—autistic disorder	0.00467	0.023	CbGeAlD
Celecoxib—MAPK14—forebrain—autistic disorder	0.0046	0.0227	CbGeAlD
Celecoxib—PDPK1—central nervous system—autistic disorder	0.0045	0.0222	CbGeAlD
Celecoxib—PDPK1—cerebellum—autistic disorder	0.0044	0.0217	CbGeAlD
Celecoxib—MAPK14—telencephalon—autistic disorder	0.00423	0.0209	CbGeAlD
Celecoxib—CA14—telencephalon—autistic disorder	0.00412	0.0203	CbGeAlD
Celecoxib—CA4—hindbrain—autistic disorder	0.00391	0.0193	CbGeAlD
Celecoxib—PDPK1—brain—autistic disorder	0.00357	0.0176	CbGeAlD
Celecoxib—CA12—eye—autistic disorder	0.00352	0.0174	CbGeAlD
Celecoxib—CA12—forebrain—autistic disorder	0.00349	0.0172	CbGeAlD
Celecoxib—CA9—digestive system—autistic disorder	0.00331	0.0163	CbGeAlD
Celecoxib—CA2—hindbrain—autistic disorder	0.00324	0.016	CbGeAlD
Celecoxib—MAPK14—digestive system—autistic disorder	0.00323	0.0159	CbGeAlD
Celecoxib—CA12—telencephalon—autistic disorder	0.00321	0.0158	CbGeAlD
Celecoxib—CA6—head—autistic disorder	0.00298	0.0147	CbGeAlD
Celecoxib—CA2—mouth—autistic disorder	0.00284	0.014	CbGeAlD
Celecoxib—MAPK14—head—autistic disorder	0.00264	0.013	CbGeAlD
Celecoxib—MAPK14—nervous system—autistic disorder	0.0025	0.0123	CbGeAlD
Celecoxib—CA12—digestive system—autistic disorder	0.00245	0.0121	CbGeAlD
Celecoxib—CA9—cerebellum—autistic disorder	0.00241	0.0119	CbGeAlD
Celecoxib—MAPK14—central nervous system—autistic disorder	0.00241	0.0119	CbGeAlD
Celecoxib—ABCC4—forebrain—autistic disorder	0.00235	0.0116	CbGeAlD
Celecoxib—MAPK14—cerebellum—autistic disorder	0.00235	0.0116	CbGeAlD
Celecoxib—CA14—cerebellum—autistic disorder	0.00229	0.0113	CbGeAlD
Celecoxib—CA4—brainstem—autistic disorder	0.00224	0.011	CbGeAlD
Celecoxib—CA4—forebrain—autistic disorder	0.00216	0.0107	CbGeAlD
Celecoxib—PTGS2—mouth—autistic disorder	0.0021	0.0103	CbGeAlD
Celecoxib—CYP2D6—hindbrain—autistic disorder	0.00206	0.0101	CbGeAlD
Celecoxib—CA12—head—autistic disorder	0.002	0.00985	CbGeAlD
Celecoxib—CA4—telencephalon—autistic disorder	0.00199	0.0098	CbGeAlD
Celecoxib—MAPK14—brain—autistic disorder	0.00191	0.00941	CbGeAlD
Celecoxib—CA12—nervous system—autistic disorder	0.0019	0.00934	CbGeAlD
Celecoxib—CA14—brain—autistic disorder	0.00186	0.00916	CbGeAlD
Celecoxib—CA2—brainstem—autistic disorder	0.00186	0.00916	CbGeAlD
Celecoxib—CA12—central nervous system—autistic disorder	0.00182	0.009	CbGeAlD
Celecoxib—CA2—eye—autistic disorder	0.00181	0.00891	CbGeAlD
Celecoxib—CA5B—head—autistic disorder	0.00179	0.00884	CbGeAlD
Celecoxib—CA2—forebrain—autistic disorder	0.00179	0.00884	CbGeAlD
Celecoxib—CA5B—nervous system—autistic disorder	0.0017	0.00838	CbGeAlD
Celecoxib—ABCC4—digestive system—autistic disorder	0.00165	0.00814	CbGeAlD
Celecoxib—CA2—telencephalon—autistic disorder	0.00165	0.00813	CbGeAlD
Celecoxib—CA5B—central nervous system—autistic disorder	0.00164	0.00807	CbGeAlD
Celecoxib—CA4—digestive system—autistic disorder	0.00152	0.00748	CbGeAlD
Celecoxib—ORM1—nervous system—autistic disorder	0.0015	0.00741	CbGeAlD
Celecoxib—CA12—brain—autistic disorder	0.00145	0.00714	CbGeAlD
Celecoxib—ORM1—central nervous system—autistic disorder	0.00145	0.00714	CbGeAlD
Celecoxib—ABCC4—head—autistic disorder	0.00135	0.00664	CbGeAlD
Celecoxib—PTGS2—forebrain—autistic disorder	0.00132	0.00652	CbGeAlD
Celecoxib—CA5B—brain—autistic disorder	0.0013	0.00641	CbGeAlD
Celecoxib—ABCC4—nervous system—autistic disorder	0.00128	0.00629	CbGeAlD
Celecoxib—CA2—digestive system—autistic disorder	0.00126	0.0062	CbGeAlD
Celecoxib—CA4—head—autistic disorder	0.00124	0.0061	CbGeAlD
Celecoxib—ABCC4—central nervous system—autistic disorder	0.00123	0.00606	CbGeAlD
Celecoxib—PTGS2—telencephalon—autistic disorder	0.00122	0.006	CbGeAlD
Celecoxib—CYP2D6—brainstem—autistic disorder	0.00118	0.00581	CbGeAlD
Celecoxib—CA4—nervous system—autistic disorder	0.00117	0.00579	CbGeAlD
Celecoxib—CYP2D6—forebrain—autistic disorder	0.00114	0.00561	CbGeAlD
Celecoxib—CA4—central nervous system—autistic disorder	0.00113	0.00557	CbGeAlD
Celecoxib—CA4—cerebellum—autistic disorder	0.0011	0.00544	CbGeAlD
Celecoxib—CYP2C9—digestive system—autistic disorder	0.00106	0.00525	CbGeAlD
Celecoxib—CYP2D6—telencephalon—autistic disorder	0.00105	0.00516	CbGeAlD
Celecoxib—CA2—head—autistic disorder	0.00103	0.00506	CbGeAlD
Celecoxib—ALB—brain—autistic disorder	0.00101	0.00497	CbGeAlD
Celecoxib—ABCC4—brain—autistic disorder	0.000976	0.00481	CbGeAlD
Celecoxib—CA2—nervous system—autistic disorder	0.000973	0.0048	CbGeAlD
Celecoxib—CA2—central nervous system—autistic disorder	0.000937	0.00462	CbGeAlD
Celecoxib—PTGS2—digestive system—autistic disorder	0.000929	0.00458	CbGeAlD
Celecoxib—CA2—cerebellum—autistic disorder	0.000916	0.00451	CbGeAlD
Celecoxib—CA4—brain—autistic disorder	0.000897	0.00442	CbGeAlD
Celecoxib—CYP3A4—digestive system—autistic disorder	0.000812	0.004	CbGeAlD
Celecoxib—CYP2D6—digestive system—autistic disorder	0.000799	0.00394	CbGeAlD
Celecoxib—PTGS2—head—autistic disorder	0.000758	0.00374	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—autistic disorder	0.00075	1	CrCbGaD
Celecoxib—CA2—brain—autistic disorder	0.000744	0.00367	CbGeAlD
Celecoxib—PTGS2—nervous system—autistic disorder	0.000719	0.00354	CbGeAlD
Celecoxib—PTGS2—central nervous system—autistic disorder	0.000692	0.00341	CbGeAlD
Celecoxib—PTGS2—cerebellum—autistic disorder	0.000676	0.00333	CbGeAlD
Celecoxib—CYP2D6—head—autistic disorder	0.000652	0.00321	CbGeAlD
Celecoxib—CYP3A4—nervous system—autistic disorder	0.000628	0.00309	CbGeAlD
Celecoxib—CYP2D6—nervous system—autistic disorder	0.000618	0.00305	CbGeAlD
Celecoxib—CYP3A4—central nervous system—autistic disorder	0.000605	0.00298	CbGeAlD
Celecoxib—CYP2D6—central nervous system—autistic disorder	0.000595	0.00293	CbGeAlD
Celecoxib—CYP2D6—cerebellum—autistic disorder	0.000581	0.00287	CbGeAlD
Celecoxib—PTGS2—brain—autistic disorder	0.000549	0.00271	CbGeAlD
Celecoxib—CYP2D6—brain—autistic disorder	0.000472	0.00233	CbGeAlD
Celecoxib—PDPK1—Signaling Pathways—PIK3CG—autistic disorder	2.66e-05	6.96e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—EGF—autistic disorder	2.63e-05	6.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.63e-05	6.88e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ADA—autistic disorder	2.61e-05	6.84e-05	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—AVP—autistic disorder	2.61e-05	6.84e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NTRK2—autistic disorder	2.61e-05	6.84e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—POMC—autistic disorder	2.61e-05	6.83e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—DRD3—autistic disorder	2.6e-05	6.81e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.58e-05	6.76e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TDO2—autistic disorder	2.58e-05	6.74e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTGS2—autistic disorder	2.58e-05	6.74e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Biological oxidations—POMC—autistic disorder	2.57e-05	6.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—TPH2—autistic disorder	2.57e-05	6.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—DHFR—autistic disorder	2.55e-05	6.68e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL5—autistic disorder	2.55e-05	6.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-A—autistic disorder	2.54e-05	6.64e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—POMC—autistic disorder	2.53e-05	6.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DPYD—autistic disorder	2.53e-05	6.61e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—PTEN—autistic disorder	2.52e-05	6.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALCA—autistic disorder	2.52e-05	6.58e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—MAPK1—autistic disorder	2.51e-05	6.56e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.49e-05	6.51e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.48e-05	6.48e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTGS2—autistic disorder	2.47e-05	6.46e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IGF1—autistic disorder	2.44e-05	6.38e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADSL—autistic disorder	2.43e-05	6.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—PTEN—autistic disorder	2.43e-05	6.36e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—MAPK1—autistic disorder	2.42e-05	6.35e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DHCR7—autistic disorder	2.42e-05	6.34e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—TSC2—autistic disorder	2.42e-05	6.34e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADSL—autistic disorder	2.41e-05	6.32e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—XDH—autistic disorder	2.39e-05	6.25e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—RORA—autistic disorder	2.38e-05	6.24e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.37e-05	6.21e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—XDH—autistic disorder	2.37e-05	6.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CACNA1C—autistic disorder	2.35e-05	6.15e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—STX1A—autistic disorder	2.34e-05	6.13e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NPAS2—autistic disorder	2.34e-05	6.13e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—STX1A—autistic disorder	2.32e-05	6.08e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NPAS2—autistic disorder	2.32e-05	6.08e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DRB1—autistic disorder	2.32e-05	6.07e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SERPINE1—autistic disorder	2.31e-05	6.05e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—EXT1—autistic disorder	2.3e-05	6.01e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC6A8—autistic disorder	2.3e-05	6.01e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALCA—autistic disorder	2.29e-05	6.01e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TCN2—autistic disorder	2.26e-05	5.92e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	2.26e-05	5.91e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—PTEN—autistic disorder	2.25e-05	5.88e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TCN2—autistic disorder	2.24e-05	5.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—MAPK1—autistic disorder	2.24e-05	5.86e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PRKCB—autistic disorder	2.23e-05	5.85e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MAOB—autistic disorder	2.23e-05	5.85e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRL—autistic disorder	2.22e-05	5.82e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MAPK1—autistic disorder	2.22e-05	5.8e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PRKCB—autistic disorder	2.2e-05	5.76e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	2.2e-05	5.76e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—MAPK1—autistic disorder	2.2e-05	5.75e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DAO—autistic disorder	2.19e-05	5.73e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS2—autistic disorder	2.18e-05	5.7e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ADA—autistic disorder	2.16e-05	5.65e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—PTEN—autistic disorder	2.15e-05	5.63e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ADA—autistic disorder	2.14e-05	5.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—DHFR—autistic disorder	2.14e-05	5.59e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.13e-05	5.56e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.12e-05	5.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—EGF—autistic disorder	2.11e-05	5.53e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ADRB2—autistic disorder	2.11e-05	5.52e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—PIK3CG—autistic disorder	2.11e-05	5.52e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—UPB1—autistic disorder	2.1e-05	5.5e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—EGF—autistic disorder	2.08e-05	5.45e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTGS2—autistic disorder	2.08e-05	5.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—TPH2—autistic disorder	2.08e-05	5.44e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—MAPK1—autistic disorder	2.05e-05	5.35e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DPYD—autistic disorder	2.04e-05	5.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRL—autistic disorder	2.03e-05	5.31e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.03e-05	5.3e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—HRAS—autistic disorder	2.01e-05	5.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AVP—autistic disorder	1.98e-05	5.18e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MAPK1—autistic disorder	1.98e-05	5.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF2—autistic disorder	1.97e-05	5.16e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—RORA—autistic disorder	1.97e-05	5.15e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ASMT—autistic disorder	1.95e-05	5.11e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM5—autistic disorder	1.95e-05	5.11e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—RORA—autistic disorder	1.95e-05	5.11e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—HRAS—autistic disorder	1.95e-05	5.09e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IGF1—autistic disorder	1.93e-05	5.05e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.92e-05	5.02e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CACNA1C—autistic disorder	1.9e-05	4.97e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL2—autistic disorder	1.87e-05	4.9e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—autistic disorder	1.86e-05	4.88e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PLA2G4A—autistic disorder	1.86e-05	4.87e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SERPINE1—autistic disorder	1.85e-05	4.84e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MAOB—autistic disorder	1.84e-05	4.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC25A12—autistic disorder	1.84e-05	4.8e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SERPINE1—autistic disorder	1.83e-05	4.8e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MAOB—autistic disorder	1.83e-05	4.79e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.83e-05	4.78e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—PTEN—autistic disorder	1.81e-05	4.75e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MEF2C—autistic disorder	1.81e-05	4.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—HRAS—autistic disorder	1.8e-05	4.7e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SLC19A1—autistic disorder	1.79e-05	4.67e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HRAS—autistic disorder	1.78e-05	4.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ITGB3—autistic disorder	1.77e-05	4.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—HRAS—autistic disorder	1.76e-05	4.61e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—PTEN—autistic disorder	1.76e-05	4.61e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.74e-05	4.56e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—DHFR—autistic disorder	1.73e-05	4.52e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—autistic disorder	1.72e-05	4.5e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—TPH2—autistic disorder	1.72e-05	4.49e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—BCL2—autistic disorder	1.71e-05	4.47e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—autistic disorder	1.7e-05	4.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—TPH2—autistic disorder	1.7e-05	4.45e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—autistic disorder	1.69e-05	4.43e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DPYD—autistic disorder	1.69e-05	4.42e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CYP19A1—autistic disorder	1.67e-05	4.38e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DPYD—autistic disorder	1.67e-05	4.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HTR2A—autistic disorder	1.65e-05	4.31e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—HRAS—autistic disorder	1.64e-05	4.3e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADSL—autistic disorder	1.59e-05	4.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—HRAS—autistic disorder	1.59e-05	4.15e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—autistic disorder	1.57e-05	4.11e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.57e-05	4.11e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.57e-05	4.11e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CACNA1C—autistic disorder	1.57e-05	4.1e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TSC2—autistic disorder	1.57e-05	4.1e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—XDH—autistic disorder	1.56e-05	4.08e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—COMT—autistic disorder	1.56e-05	4.07e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CACNA1C—autistic disorder	1.56e-05	4.07e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTP1—autistic disorder	1.55e-05	4.05e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MAOA—autistic disorder	1.54e-05	4.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—autistic disorder	1.53e-05	4.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—autistic disorder	1.53e-05	4.01e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—STX1A—autistic disorder	1.53e-05	4.01e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NPAS2—autistic disorder	1.53e-05	4.01e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—autistic disorder	1.52e-05	3.97e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAT—autistic disorder	1.51e-05	3.94e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL2—autistic disorder	1.5e-05	3.94e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—autistic disorder	1.5e-05	3.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HLA-A—autistic disorder	1.5e-05	3.92e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.5e-05	3.91e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL2—autistic disorder	1.48e-05	3.88e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TCN2—autistic disorder	1.48e-05	3.87e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.46e-05	3.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCB—autistic disorder	1.44e-05	3.78e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK1—autistic disorder	1.43e-05	3.75e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TSC2—autistic disorder	1.43e-05	3.74e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—DHFR—autistic disorder	1.43e-05	3.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PLA2G4A—autistic disorder	1.42e-05	3.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—autistic disorder	1.42e-05	3.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PTEN—autistic disorder	1.42e-05	3.71e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—DHFR—autistic disorder	1.41e-05	3.7e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ADA—autistic disorder	1.41e-05	3.69e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—autistic disorder	1.4e-05	3.66e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CG—autistic disorder	1.38e-05	3.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APC—autistic disorder	1.38e-05	3.62e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—EGF—autistic disorder	1.37e-05	3.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—autistic disorder	1.36e-05	3.57e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CYP19A1—autistic disorder	1.35e-05	3.54e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—POMC—autistic disorder	1.32e-05	3.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—autistic disorder	1.3e-05	3.41e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—RORA—autistic disorder	1.29e-05	3.37e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.27e-05	3.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—autistic disorder	1.27e-05	3.31e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APC—autistic disorder	1.26e-05	3.3e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—COMT—autistic disorder	1.26e-05	3.29e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—autistic disorder	1.26e-05	3.29e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTP1—autistic disorder	1.25e-05	3.28e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MAOA—autistic disorder	1.25e-05	3.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—EGF—autistic disorder	1.25e-05	3.26e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAT—autistic disorder	1.22e-05	3.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MAOB—autistic disorder	1.21e-05	3.16e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—autistic disorder	1.2e-05	3.15e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.19e-05	3.12e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—autistic disorder	1.17e-05	3.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK1—autistic disorder	1.15e-05	3.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PLA2G4A—autistic disorder	1.15e-05	3.01e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—autistic disorder	1.15e-05	3.01e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—HRAS—autistic disorder	1.15e-05	3.01e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK1—autistic disorder	1.13e-05	2.97e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—TPH2—autistic disorder	1.12e-05	2.93e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CYP19A1—autistic disorder	1.12e-05	2.92e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CYP19A1—autistic disorder	1.11e-05	2.9e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DPYD—autistic disorder	1.1e-05	2.89e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—autistic disorder	1.1e-05	2.88e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—autistic disorder	1.1e-05	2.88e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—autistic disorder	1.1e-05	2.87e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CG—autistic disorder	1.06e-05	2.76e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.04e-05	2.72e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—COMT—autistic disorder	1.04e-05	2.72e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTP1—autistic disorder	1.03e-05	2.71e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MAOA—autistic disorder	1.03e-05	2.7e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—COMT—autistic disorder	1.03e-05	2.7e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CACNA1C—autistic disorder	1.03e-05	2.68e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTP1—autistic disorder	1.03e-05	2.68e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MAOA—autistic disorder	1.02e-05	2.68e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—autistic disorder	1.02e-05	2.66e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAT—autistic disorder	1.01e-05	2.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—POMC—autistic disorder	1.01e-05	2.63e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAT—autistic disorder	9.98e-06	2.61e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL2—autistic disorder	9.73e-06	2.55e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—autistic disorder	9.5e-06	2.49e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G4A—autistic disorder	9.5e-06	2.49e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—autistic disorder	9.47e-06	2.48e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G4A—autistic disorder	9.42e-06	2.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—autistic disorder	9.42e-06	2.47e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—DHFR—autistic disorder	9.33e-06	2.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HRAS—autistic disorder	9.24e-06	2.42e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PTEN—autistic disorder	9.16e-06	2.4e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—HRAS—autistic disorder	9.11e-06	2.38e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—autistic disorder	9.1e-06	2.38e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—autistic disorder	9.02e-06	2.36e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—autistic disorder	8.85e-06	2.31e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CG—autistic disorder	8.55e-06	2.24e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—autistic disorder	8.4e-06	2.2e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PTEN—autistic disorder	8.35e-06	2.19e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—autistic disorder	8.33e-06	2.18e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—POMC—autistic disorder	8.14e-06	2.13e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—autistic disorder	7.82e-06	2.05e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—autistic disorder	7.75e-06	2.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK1—autistic disorder	7.44e-06	1.95e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP19A1—autistic disorder	7.31e-06	1.91e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CG—autistic disorder	7.06e-06	1.85e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CG—autistic disorder	7e-06	1.83e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PTEN—autistic disorder	6.99e-06	1.83e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—COMT—autistic disorder	6.79e-06	1.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK1—autistic disorder	6.79e-06	1.78e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTP1—autistic disorder	6.76e-06	1.77e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MAOA—autistic disorder	6.75e-06	1.77e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—POMC—autistic disorder	6.72e-06	1.76e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—POMC—autistic disorder	6.66e-06	1.74e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAT—autistic disorder	6.58e-06	1.72e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—autistic disorder	6.49e-06	1.7e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G4A—autistic disorder	6.21e-06	1.63e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—autistic disorder	6.21e-06	1.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—HRAS—autistic disorder	5.98e-06	1.56e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—autistic disorder	5.95e-06	1.56e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—autistic disorder	5.72e-06	1.5e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTEN—autistic disorder	5.66e-06	1.48e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—autistic disorder	5.49e-06	1.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—HRAS—autistic disorder	5.45e-06	1.43e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—autistic disorder	5.36e-06	1.4e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—autistic disorder	5.31e-06	1.39e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—autistic disorder	5.22e-06	1.37e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—autistic disorder	5.11e-06	1.34e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTEN—autistic disorder	4.67e-06	1.22e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTEN—autistic disorder	4.63e-06	1.21e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CG—autistic disorder	4.61e-06	1.21e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—POMC—autistic disorder	4.39e-06	1.15e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—autistic disorder	3.5e-06	9.17e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTEN—autistic disorder	3.05e-06	7.99e-06	CbGpPWpGaD
